Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, Super Bowl and cancer
Don't call it a comeback: Pfizer returns to Super Bowl with ad pledging to 'knock out' cancer
Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for
Watch Pfizer’s Super Bowl ad showing a patient’s cancer-fighting story
Pfizer is again shining a spotlight on its oncology treatments with its second consecutive Super Bowl ad, a 60-second commercial that will air in the first quarter of the game on Sunday. The ad begins with a young boy in a hospital bed watching announcer Michael Buffer on TV.
Pfizer Prepares To 'Knock Out' Cancer In Super Bowl Spot
"Knock Out," features a boy in boxing trunks symbolizing the battle against cancer as LL Cool J's "Mama Said Knock You Out" plays.
Pfizer Teams Up With LL Cool J In Super Bowl Ad, Literally Fighting Cancer
Picking up from where last year's Big Game ad debut left off, Pfizer wants to bring a note of resilience and motivation to those fighting cancer in its Super Bowl 59 spot. In the ad, a young boy gets out of his hospital bed,
2d
on MSN
Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr.
Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...
1d
on MSN
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
FierceBiotech
1d
Pfizer builds out oncology team with appointment of Novartis vet Jeff Legos
In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...
Pharm Exec
1h
Pfizer Appoints Jeffrey Legos as Chief Oncology Officer
Legos holds a PhD in physiology from Temple University and an MBA in finance from Villanova University. He has also written ...
2d
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
Pfizer shares rose early Tuesday due to higher than expected demand for its COVID vaccine, but quickly sunk 2.3% after ...
3d
Pfizer shows profit growth from cost cuts and steadier COVID sales
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...
2d
Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down
Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...
FierceBiotech
3d
Pfizer axes B7-H4 ADC, triggering $1B impairment charge as blockbuster vision evaporates
Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...
BioPharma Dive
1d
Pfizer taps a former Novartis exec to lead cancer drug push
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
Crain's New York
3d
Pfizer gets unexpected boost from Covid vaccine and pill
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...
3d
Pfizer’s Covid Boost Overshadowed by Kennedy Threat to Vaccines
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...
2d
on MSN
Pfizer Falls on RFK’s Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered.
CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Super Bowl
COVID vaccine
Wall Street
Novartis
Albert Bourla
Feedback